中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
拉罗皮兰 |
laropiprant |
571170-77-9 |
C21H19ClFNO4S |
|
拉罗替尼硫酸盐 |
larotrectinib sulfate |
1223405-08-0 |
C21H22F2N6O2*H2O4S |
|
拉罗替尼杂质1 |
(R)-N-(5-((S)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide |
2409590-08-3 |
C21H22F2N6O2 |
|
拉罗替尼 |
larotrectinib |
1223403-58-4 |
C21H22F2N6O2 |
|
拉波定 |
<i>N</i>-(8-ethoxy-[5]quinolyl)-benzamide |
605-90-3 |
C18H16N2O2 |
|
拉扎贝胺盐酸盐 |
N-(2-aminoethyl)-5-chloropyridine-2-carboxamide;hydron;chloride |
—— |
C8H11Cl2N3O |
|
拉扎贝胺 |
lazabemide |
103878-84-8 |
C8H10ClN3O |
|
拉帕替尼羟胺 |
N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[hydroxy[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine |
1360431-86-2 |
C29H26ClFN4O5S |
|
拉帕替尼杂质L |
5-(4-(4-benzyloxy-phenylamino)-quinazolin-6-yl)-furan-2-carbaldehyde |
202196-46-1 |
C26H19N3O3 |
|
拉帕替尼杂质K |
5-(4-{3-chloro-4-benzyloxyanilino}-6-quinazolinyl)-furan-2-carbaldehyde |
231278-83-4 |
C26H18ClN3O3 |
|
拉帕替尼杂质I |
4-Quinazolinamine, N-[3-chloro-4-[(2-fluorophenyl)methoxy]phenyl]-6-iodo- |
1393175-04-6 |
C21H14ClFIN3O |
|
拉帕替尼杂质H |
(4-Benzyloxy-phenyl)-(6-iodo-quinazolin-4-yl)-amine |
202198-16-1 |
C21H16IN3O |
|
拉帕替尼杂质F |
(6-iodo-(4-(3-fluorobenzyloxy)-phenyl)-quinazolin-4-yl)amine |
231278-25-4 |
C21H15FIN3O |
|
拉帕替尼杂质8 |
4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-6-(5-hydroxymethylfuran-2-yl)quinazoline |
320337-48-2 |
C26H19ClFN3O3 |
|
拉帕替尼杂质8 |
N-{3-chloro-4-[(2-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazoline-4-amine |
1393112-45-2 |
C29H26ClFN4O4S |
|
拉帕替尼杂质32 |
5-[4-({3-chloro-4-[(2-fluorobenzyl)oxy]phenyl}amino)quinazoline-6-yl]furan-2-carbaldehyde |
1393112-44-1 |
C26H17ClFN3O3 |
|
拉帕替尼杂质2 |
Lapatinib metabolite M5 |
1807733-95-4 |
C29H25ClFN4O4S+ |
|
拉帕替尼杂质16 |
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)quinazolin-4-amine |
845271-73-0 |
C21H15ClFN3O |
|
拉帕替尼杂质10 |
N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-carboxy-2-furyl)-4-quinazolinamine |
1152131-73-1 |
C26H17ClFN3O4 |
|
拉帕替尼杂质1 |
Lapatinib metabolite M1 |
1268997-70-1 |
C22H21ClN4O4S |
|
拉帕替尼杂质 |
5-(4-{4-(3-fluorobenzyloxy)anilino}-6-quinazolinyl)-furan-2-carbaldehyde |
746591-42-4 |
C26H18FN3O3 |
|
拉帕替尼-D7二对甲苯磺酸盐 |
[2H]-Lapatinib ditosylate-d7 |
1009307-24-7 |
2C7H8O3S*C29H26ClFN4O4S |
|
拉帕替尼 |
lapatanib |
231277-92-2 |
C29H26ClFN4O4S |
|
拉帕司他 |
N-[[(3R,5S)-1-(3-hydroxy-2,2-dimethylpropyl)-7-chloro-5-(2,3-dimethoxyphenyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]acetyl]piperidine-4-acetic acid |
189059-71-0 |
C31H39ClN2O8 |
|
拉帕司他 |
(1-{2-[(3R,5S)-1-(3-Acetoxy-2,2-dimethyl-propyl)-7-chloro-5-(2,3-dimethoxy-phenyl)-2-oxo-1,2,3,5-tetrahydro-benzo[e][1,4]oxazepin-3-yl]-acetyl}-piperidin-4-yl)-acetic acid |
189060-13-7 |
C33H41ClN2O9 |
|
拉尼兰诺 |
lanifibranor |
927961-18-0 |
C19H15ClN2O4S2 |
|
拉奇霉素 |
CC-1065 |
69866-21-3 |
C37H33N7O8 |
|
拉坦前列腺素内酯二醇 |
(3aR,4R,5R,6aS)-5-hydroxy-4-((R)-3-hydroxy-5-phenylpentyl)hexahydro-2H-cyclopenta[b]furan-2-one |
145667-75-0 |
C18H24O4 |
|
拉坦前列腺素 |
(3aR,4R,5R,6aS)-5-hydroxy-4-((S,E)-3-hydroxy-5-phenylpent-1-en-1-yl)hexahydro-2H-cyclopenta[b]furan-2-one |
41639-74-1 |
C18H22O4 |
|
拉伏替丁 |
1-Methyl-5-[[3-[3-(1-piperidinylmethyl)phenoxy]-propyl]amino]-1H-1,2,4-triazole-3-methanol |
76956-02-0 |
C19H29N5O2 |
|
拂来星-d2 |
2-Amino-5-chlor-benzoxazole-4,6-d(2) |
24160-33-6 |
C7H5ClN2O |
|
折那司他 |
zenarestat |
112733-06-9 |
C17H11BrClFN2O4 |
|
折替多林 |
1-(m-Chlorphenyl)-3-<2-(3,3-dimethylazetidin-1-yl)-ethyl>-2-imidazolidinon |
51940-78-4 |
C16H22ClN3O |
|
抗螨挫 |
5,5-Dichloro-1-phenoxycarbonyl-2-trifluormethylbenzimidazol |
14255-88-0 |
C15H7Cl2F3N2O2 |
|
抗癌医药中间体 |
(Z)-5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrol-3-propanoic acid |
210644-62-5 |
C18H18N2O3 |
|
抗生素167A |
18-O-demethyl cervinomycin A<sub>2</sub> |
113537-08-9 |
C28H19NO9 |
|
抗氧剂136 |
5,7-di-tert-butyl-3-(3,4-dimethyl-phenyl)-3H-benzofuran-2-one |
164391-52-0 |
C24H30O2 |
|
抗敏安DI-N氧化物 |
Doxylamine Di-N-Oxide |
105176-70-3 |
C17H22N2O3 |
|
抗头孢吡肟 |
cefepime |
97164-57-3 |
C19H24N6O5S2 |
|
抗坏血酸镁 |
Magnesium ascorbate hydrate |
15431-40-0 |
C6H8MgO6 |
|
抗坏血酸钙 |
L-Ascorbic acid, calcium salt (2:1) |
5743-27-1 |
C6H8CaO6 |
|
抗坏血酸自由基 |
ascorbic acid radical |
213530-28-0 |
C6H7O6 |
|
抗坏血酸盐-3-磷酸酯 |
L-Ascorbinsaeure-3-phosphat |
21090-54-0 |
C6H9O9P |
|
抗坏血酸原 A |
ascorbigen |
26676-89-1 |
C15H15NO6 |
|
抗坏血酸2-硫酸盐 |
Ascorbic acid 2-sulfate |
37627-95-5 |
C6H8O9S |
|
抗坏血酸-铁(III)络合物 |
Fe(3+)-Ascorbate |
91260-12-7 |
C6H7FeO6+2 |
|
抗坏血酸 |
ascorbate |
299-36-5 |
C6H7O6 |
|
抗-11-氧杂三环[4.3.1.12,5]十一碳-3-烯-10-酮 |
(1α,2β,5β,6α)-11-oxatricyclo[4.3.1.1<sup>2,5</sup>]undec-3-en-10-one |
42768-72-9 |
C10H12O2 |
|
抑草津 |
2-Chlor-6-diethylamino-6-isopropylamino-s-triazin |
1912-25-0 |
C10H18ClN5 |
|
抑芽丹 |
Maleic hydrazide |
123-33-1 |
C4H4N2O2 |
|